Trends in US sunscreen formulations: Impact of increasing spray usage - 13/12/17
Doi : 10.1016/j.jaad.2017.07.040
Rebeca W. Teplitz, BA a, Alex M. Glazer, MD b, ⁎ 
, Ryan M. Svoboda, MD, MS c, Darrell S. Rigel, MD, MS d
, Ryan M. Svoboda, MD, MS c, Darrell S. Rigel, MD, MS d a New York Institute of Technology, College of Osteopathic Medicine, Old Westbury, New York
b Department of Medicine, Division of Dermatology, University of Arizona College of Medicine, Tucson, Arizona
c National Society for Cutaneous Medicine, New York, New York
d Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York
∗Correspondence to: Alex M. Glazer, MD, Clinical Research Fellow, National Society for Cutaneous Medicine, 35 E 35th St, #208, New York, NY 10016Clinical Research FellowNational Society for Cutaneous Medicine35 E 35th St, #208New YorkNY10016
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
© 2017
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 78 - N° 1
P. 187-189 - janvier 2018 Retour au numéro
Article précédent
- Interrater reliability for histopathologic diagnosis of keratinocyte carcinomas
- Nicholas F. Leader, Alexander D. Means, Leslie Robinson-Bostom, Gladys H. Telang, Caroline S. Wilkel, Martin A. Weinstock, Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial group
- Nifedipine cream versus sildenafil cream for patients with secondary Raynaud phenomenon: A randomized, double-blind, controlled pilot study
- Ximena Wortsman, Pablo Del Barrio-Díaz, Rodrigo Meza-Romero, Christine Poehls-Risco, Cristián Vera-Kellet
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?